Wells Fargo’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-200
| Closed | -$104 | – | 6634 |
|
|
2024
Q4 | $104 | Sell |
200
-150
| -43% | -$78 | ﹤0.01% | 5906 |
|
|
2024
Q3 | $1.13K | Hold |
350
| – | – | ﹤0.01% | 5698 |
|
|
2024
Q2 | $1.05K | Sell |
350
-193
| -36% | -$579 | ﹤0.01% | 5700 |
|
|
2024
Q1 | $2.53K | Buy |
543
+3
| +0.6% | +$14 | ﹤0.01% | 5599 |
|
|
2023
Q4 | $2.24K | Buy |
540
+10
| +2% | +$41 | ﹤0.01% | 5645 |
|
|
2023
Q3 | $1.59K | Sell |
530
-4
| -0.7% | -$12 | ﹤0.01% | 5754 |
|
|
2023
Q2 | $1.31K | Sell |
534
-4,831
| -90% | -$11.9K | ﹤0.01% | 5964 |
|
|
2023
Q1 | $12.1K | Buy |
5,365
+4,222
| +369% | +$9.54K | ﹤0.01% | 5479 |
|
|
2022
Q4 | $3.99K | Sell |
1,143
-20,710
| -95% | -$72.3K | ﹤0.01% | 5503 |
|
|
2022
Q3 | $809K | Sell |
21,853
-3,179
| -13% | -$118K | ﹤0.01% | 3167 |
|
|
2022
Q2 | $476K | Buy |
25,032
+802
| +3% | +$15.3K | ﹤0.01% | 3558 |
|
|
2022
Q1 | $654K | Buy |
24,230
+15,841
| +189% | +$428K | ﹤0.01% | 3961 |
|
|
2021
Q4 | $189K | Buy |
8,389
+7,116
| +559% | +$160K | ﹤0.01% | 4928 |
|
|
2021
Q3 | $33K | Sell |
1,273
-8,272
| -87% | -$214K | ﹤0.01% | 5471 |
|
|
2021
Q2 | $306K | Sell |
9,545
-2,767
| -22% | -$88.7K | ﹤0.01% | 4571 |
|
|
2021
Q1 | $434K | Sell |
12,312
-30,822
| -71% | -$1.09M | ﹤0.01% | 4458 |
|
|
2020
Q4 | $1.38M | Buy |
43,134
+8,189
| +23% | +$263K | ﹤0.01% | 3720 |
|
|
2020
Q3 | $1.31M | Sell |
34,945
-4,013
| -10% | -$151K | ﹤0.01% | 3581 |
|
|
2020
Q2 | $1.74M | Buy |
38,958
+27,273
| +233% | +$1.22M | ﹤0.01% | 3309 |
|
|
2020
Q1 | $399K | Buy |
11,685
+1,526
| +15% | +$52.1K | ﹤0.01% | 4077 |
|
|
2019
Q4 | $396K | Buy |
+10,159
| New | +$396K | ﹤0.01% | 4437 |
|